Sagimet Biosciences (SGMT) Enterprise Value (2022 - 2026)
Sagimet Biosciences (SGMT) posted quarterly Enterprise Value of -$104.5 million for Q1 2026, up 27.69% year-over-year from -$81.9 million in Q1 2025, and up 7.59% quarter-over-quarter from -$113.1 million in Q4 2025.
Sagimet Biosciences (SGMT) Enterprise Value (2022 - 2026) Analysis & Trends
Sagimet Biosciences' Enterprise Value history runs 5 years deep, the most recent figure standing at -$104.5 million for Q1 2026.
- In Q1 2026, Enterprise Value rose 27.69% year-over-year to -$104.5 million; the TTM figure through Mar 2026 stood at -$104.5 million (up 27.69% YoY), while the FY2025 annual figure was -$113.1 million, up 25.21% from the prior year.
- Enterprise Value for Q1 2026 stood at -$104.5 million, up from -$113.1 million in the prior quarter.
- The five-year high for Enterprise Value was -$18.5 million in Q2 2023, with the low at -$193.7 million in Q1 2024.
- The 5-year median for Enterprise Value is -$116.7 million (2025), against an average of -$116.6 million.
- The sharpest annual moves came in 2024 and 2026: Enterprise Value plunged 798.92% in 2024, then rose 27.69% in 2026.
- Sagimet Biosciences' Enterprise Value stood at -$32.3 million in 2022, then slumped by 193.39% to -$94.9 million in 2023, then plunged by 59.38% to -$151.2 million in 2024, then gained by 25.21% to -$113.1 million in 2025, then increased by 7.59% to -$104.5 million in 2026.
- Business Quant data shows SGMT's Enterprise Value at -$104.5 million in Q1 2026, -$113.1 million in Q4 2025, and -$116.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | Sagimet Biosciences | 649.79 Mn | 649.79 Mn | - | -240.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -240.13 Mn |
| Mar 31, 2026 | -104.54 Mn |
| Dec 31, 2025 | -113.12 Mn |
| Sep 30, 2025 | -116.69 Mn |
| Jun 30, 2025 | -125.41 Mn |
| Mar 31, 2025 | -144.57 Mn |
| Dec 31, 2024 | -151.25 Mn |
| Sep 30, 2024 | -152.49 Mn |
| Jun 30, 2024 | -166.37 Mn |
| Mar 31, 2024 | -193.71 Mn |
| Dec 31, 2023 | -94.90 Mn |
| Sep 30, 2023 | -101.84 Mn |
| Jun 30, 2023 | -18.51 Mn |
| Dec 31, 2022 | -32.35 Mn |